Web14 apr. 2024 · Abstract. BackgroundPoly (ADP-ribose) polymerase inhibitors (PARPi) have demonstrated efficacy in treating solid tumors with Homologous Recombination Deficiency (HRD), the inability to repair DNA double-stranded breaks through the Homologous Recombination Repair (HRR) pathway. Specific genetic and epigenetic alterations result … WebKimberly is the Chief Executive Officer at Zentalis Pharmaceuticals. Prior to joining Zentalis, she served as Chief Medical Officer and Senior Vice President, Oncology Clinical …
Tempus Labs, Inc. on LinkedIn: #itsabouttime #aacr #aacr22 # ...
WebGet Kim Blackwell's email address (k*****@zentalis.com) and phone number (919-684-....) at RocketReach. Get 5 free searches. Rocketreach finds email, phone & social media for … Web16 mei 2024 · About Kimberly Blackwell, MD Dr. Blackwell has been an independent director of Zentalis since 2024. Until assuming the CEO role at Zentalis, she served as … secretary wray
Zentalis Pharmaceuticals appoints Kimberly Blackwell as top boss
WebThere are 100+ professionals named "Kimberly Blackwell", who use LinkedIn to exchange information, ... Tempus Labs, Inc., +2 more Duke University, +2 more Kim Blackwell ... Web17 mrt. 2024 · Dr. Blackwell is the Co-founder of Cereius and the Chief Medical Officer at Tempus, Inc. She is a board-certified medical oncologist, having train ed at Mayo Clinic … Web16 mei 2024 · Dr. Blackwell is a current member of Zentalis’ Board and previously served as Chief Medical Officer of Tempus Labs and held clinical development leadership roles … secretary wormuth ausa